Serum levels of profibrotic (TGF-β1 and CXCL4) markers and changes of these serum concentrations were similar in HCV-monoinfected and HIV/HCV coinfected individuals, suggesting that liver fibrosis regulatory mechanisms function in a similar mode in both groups of patients. The gene discussed is TGFB1; the disease is Hepatic fibrosis.